Adapting The Adpkd Outcomes Model to Predict Cost Consequence In Italian Patients With Autosomal Dominant Polycystic Kidney Disease (Adpkd) Treated With Jinarc (Tolvaptan)

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2930
https://www.valueinhealthjournal.com/article/S1098-3015(15)05011-1/fulltext
Title : Adapting The Adpkd Outcomes Model to Predict Cost Consequence In Italian Patients With Autosomal Dominant Polycystic Kidney Disease (Adpkd) Treated With Jinarc (Tolvaptan)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)05011-1&doi=10.1016/j.jval.2015.09.2930
First page : A755
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 2333
Categories :
Tags :
Regions :
ViH Article Tags :